Journals By Industry - Avian Influenza

SAN JOSE, Calif. -- Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus...

-More than 25,000 people have started treatment for hepatitis C with INCIVEK([R]), positioning Vertex for continued growth, earnings and cashflow in 2012- -Preparations for approval and launch of KALYDECO(TM) ongoing; additional studies of...

CAMBRIDGE, Mass. -- Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1...

Strengths...

Strengths Well-established market presence in Singapore. A strong product portfolio, including transplantation and immunology, oncology, cardiovascular diseases, central nervous system (CNS) disorders, endocrine, gastrointestinal, dermatology and ophthalmic treatments. One of the fastest-growing global...

Strengths Strong OTC product portfolio. One of the leading global pharmaceutical companies. Long-established local manufacturing presence. Production of the influenza drug Relenza (zanamivir) which is also used as a preventative measure against avian...

Strengths...

Strengths One of leading multinationals in the world. Among the leading foreign firms in Turkey. Sizeable branded product portfolio. Presence in the diagnostics sector. Local production facilities. Weaknesses Considerable counterfeit drug trade in...

Strengths The company is the largest food producer by sales in the high-growth Brazilian market. In recent years, strong focused on development of higher-margin value-added products. Has invested heavily in new facilities in...

Strengths One of the leading providers of prescription medicines in Australia. Strong historical presence and expanding product portfolio. Presence in the vaccines segment, the potential of which has been boosted in recent times...

VIENNA, Va. -- CEL-SCI Corporation (NYSE AMEX: CVM) is in the process of expanding its Phase III clinical trial ofthe investigational therapyMultikine (Leukocyte Interleukin, Injection)* to 4 additional European countries - Spain, Czech...

VIENNA, Va. -- CEL-SCI Corporation (NYSE AMEX: CVM) reported financial results today for the fiscal year ended September 30, 2011. CEL-SCI's net loss available to common shareholders for the fiscal year 2011 was...

SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an emerging international biotechnology provider of cell and gene therapy solutions including encapsulation of live cells and services through their associate SG Austria, released information today...

The new year will pose unprecedented challenges and risks for organizations worldwide ANNAPOLIS, Md. -- iJET International Inc., a leading provider of global intelligence and business resiliency services, today issued its forecast for...

VIENNA, Va. -- CEL-SCI Corporation (NYSE AMEX: CVM) provided an update today of the progress of its Phase III clinical trial ofitsinvestigational therapy Multikine (Leukocyte Interleukin, Injection)*, which is currently being investigated in...

Submission Represents a Major Advance for the Company WEST HAVEN, Conn. -- NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that it has submitted a pre-IND Meeting Request to the US FDA....

SAN DIEGO -- PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has engaged James McClenahan as a business development executive targeting key accounts in...

This single synthetic vaccine generated a four-fold or greater rise in hemagglutination inhibition (HAI) titers in 50% of boosted subjects in its Phase I clinical study. Inovio's SynCon vaccine design process uses a...

Contributed by Dr Adrian Rogers, a clinical assistant, and Dr Lisa Ford, a clinical lecturer, at the Well Travelled Clinic, Liverpool School of Tropical Medicine. Section 1: Epidemiology and aetiology The first historical...